Profession Notes

Florida Receives NIH Grant for Aphasia Treatment University of Florida researchers recently were awarded a $5 million grant from the National Institutes of Health to test several treatments for stroke-induced communication problems, collectively known as aphasia. The concept of neural plasticity--the brain being adaptable and able to create new pathways to regain lost function--is the basis for this research that focuses on a combination of drugs and rehabilitation in the form of mental and phy

Written byKate Devine
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

University of Florida researchers recently were awarded a $5 million grant from the National Institutes of Health to test several treatments for stroke-induced communication problems, collectively known as aphasia. The concept of neural plasticity--the brain being adaptable and able to create new pathways to regain lost function--is the basis for this research that focuses on a combination of drugs and rehabilitation in the form of mental and physical exercises. According to the project's principal investigator, Leslie Gonzales-Rothi, professor of neurology at UF's College of Medicine, "Although results of treatments for individual patients are expected within the first year of the four-year program that was initiated last June, there will not be enough data compiled from which to draw broad conclusions until project completion." Researchers plan to do pre- and post-functional magnetic resonance imaging (fMRI) of patients to understand the physiological changes due to treatment, with the intent ultimately to be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies